Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluate the Safety of Combination of Orectalip® (Oxaliplatin), Fluorouracil and Leucovorin as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer

NCT02284529 is registered in ClinicalTrials.gov with Sinphar Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT02284529
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02284529 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluate the Safety of Combination of Orectalip® (Oxaliplatin), Fluorouracil and Leucovorin as Adjuvant Treatment for High-risk Stage-Ⅱ Colorectal Cancer
Lead sponsor
Sinphar Pharmaceutical Co., Ltd
Phase
Phase 4
Overall status
Completed
Start date
October 31, 2012
Completion date
September 30, 2014
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stage-Ⅱ colorectal cancer